Presenter: Margaret Liu, M.D.

Title: Early Terli? Terlipressin vs Midodrine/Octreotide in the Treatment of Type 1 Hepatorenal Syndrome

Learning Objectives:

• Review the definition of and treatment strategies for Type 1 hepatorenal syndrome
• Compare the efficacy of terlipressin + albumin vs octreotide + midodrine + albumin in treatment in patients with Type 1 HRS

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.